Sheilagh Maguiness, MD
Associate Professor, Department of Dermatology
Contact Info
Associate Professor, Department of Dermatology
MD, University of Western Ontario, London, ON, Canada
Residency, University of Alberta, Edmonton, AB, Canada
Fellowship, University of California-San Francisco (Pediatric Dermatology)
Summary
If you would like to schedule an appointment with Dr. Maguiness, please call: (612) 365-6777 - Pediatric Dermatology Clinic
(763) 898-1440 - M Health Maple Grove Clinic
Awards & Recognition
2019 Resident Teacher of the Year, Department of Dermatology University of Minnesota 2018 Distinguished Mentorship Award, University of Minnesota Medical School 2018 Minnesota Monthly Magazine:Top Doctors, 2016, 2017, 2018, 2019 2018 Academic Dermatology Advanced Leadership Program, competitively selected to participate 2017 Presidential Citation, American Academy of Dermatology for contribution to the Basic Dermatology Curriculum 2017 University of Minnesota Department of Dermatology Research Day Outstanding Abstract 2015 University of Minnesota Masonic Children’s Hospital Cross Departmental Research Grant 2015 Walt Tunnessen Visiting Professor Speaker List, American Academy of Pediatrics 2015 National Eczema Association ‘Hero’ 2011 Selected Member, Academic Dermatology Leadership Program, AAD 2003 First Place, Resident Research Award, Canadian Dermatology Association 2001 Norma Fletcher Award, University of Western Ontario 2000 Ivan Smith Award, University of Toronto
Professional Associations
Minnesota Dermatological Society 2014-Present American Academy of Pediatrics Section on Dermatology 2014- present American Academy of Pediatrics 2013-Present Section on Dermatology, Executive Committee 2017-Present Chair, AAP Section on Dermatology Education Sub-committee 2018-Present Pediatric Dermatology Research Alliance 2013-Present New England Dermatologic Society 2011-2014 International Society for the Study of Vascular Anomalies 2010-Present ISSVA Poster Judging Committee 2018 American Board of Dermatology 2007-Present Royal College of Physicians and Surgeons of Canada 2007-Present Society for Pediatric Dermatology 2006-Present Vice President Education and Career Development 2017-Present Chair, Education Committee 2014-2017 Annual Meeting Course Director 2014 Poster Judging Committee 2013
Research
Publications
Recent Key Publications
1.Frieden IJ, Püttgen KB, Drolet BA, Garzon MC, Chamlin SL, Pope E, Mancini AJ, Lauren CT, Mathes EF, Siegel DH, Gupta D, Maguiness, S. Management of Infantile Hemangiomas during the COVID Pandemic. Pediatric Dermatology. 2020 Apr 16.
2.Reynolds SD, Mathur AN, Chiu YE, Brandling-Bennett H, Pope E, Siegel M, Holland K, Paller A, Siegfried E, Tom W, Lara-Corrales I, Tollefson M, Maguiness S, Eichenfield L, Sugarman J, Frieden I, Oza V, Cipriano S, Huang J, Shah S, Lauren C, Castelo-Soccio L, McMahon P, Cordoro K. Systemic immunosuppressive therapy for inflammatory skin diseases in children: Expert consensus-based guidance for clinical decision-making during the COVID-19 pandemic [published online ahead of print, 2020 Apr 22]. Pediatr Dermatol. 2020;10.1111/pde.14202. doi:10.1111/pde.14202
3.Luu M, Halbert A, Yan A, Rubin A, McMahon P, Liang M, Vadeboncoeur S, Frieden IJ, Maguiness S. Cutaneous manifestations of congenital malignant rhabdoid tumor: Unusual papillomatous plaques and other skin presentations. Pediatric Dermatology. 2020 Apr 23.
4.Correll CK, Miller DD, Maguiness SM. Treatment of Childhood-Onset Lupus Erythematosus Panniculitis With Rituximab. JAMA dermatology. 2020 May 1;156(5):566-9.
5.Dodds M, Tollefson M, Castelo‐Soccio L, Garzon MC, Hogeling M, Hook K, Boull C, Maguiness S. Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series. Pediatric Dermatology. 2020 Mar;37(2):272-7.
6.Nguyen CV, Collier S, Merten AH, Maguiness SM, Hook KP. Tinea capitis: A single‐institution retrospective review from 2010 to 2015. Pediatric dermatology. 2020 Mar;37(2):305-10.
7.Dodds M, Maguiness S. Topical sirolimus therapy for epidermal nevus with features of acanthosis nigricans. Pediatric dermatology. 2019 Jul;36(4):554-5.
8.Schultz B, Miller DD, Maguiness S. Diffuse, mottled hyperpigmentation and mutations in LMNA gene in a 5‐year‐old boy, his mother, and his grandmother: Atypical progeroid syndrome. Pediatric dermatology. 2019 Nov;36(6):913-7.
9.Liszewski W, Maguiness S, Greengard E, Boull C. The incidence of pediatric malignant soft tissue tumors of the skin and subcutaneous tissue. Pediatr Dermatol. 2018;35(6):e427‐e429. doi:10.1111/pde.13669
10.Mansh M, Riskalla M, Maguiness S.Necrotizing Anogenital Ulcer in a Healthy 8-Month-Old Male.JAMA Dermatol. Published online May 16, 2018. Doi:10.001/jamadermatol.2018.0287.
Clinical
Board Certifications
Board Certifications
Dermatology, Pediatric Dermatology Fellow of the Royal College of Physicians and Surgeons of Canada
Care Philosophy
I am a pediatric dermatologist with special interest in the diagnosis and management of vascular anomalies including hemangiomas, capillary malformations (port wine stains) and complex vascular birthmarks. I am committed to patient care, teaching and research in all aspects of pediatric der
Clinical Interests
Vascular Anomalies: Hemangiomas, Port Wine Stain/Capillary malformations, Venous malformations Laser treatment of Vascular Birthmarks Pigmented lesions and other Birthmarks Inflammatory skin diseases: Atopic Dermatitis, Psoriasis